Literature DB >> 12368187

Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative study.

Victoria Zhukareva1, Keyur Shah, Kunihiro Uryu, Heiko Braak, Kelly Del Tredici, Sonali Sundarraj, Christopher Clark, John Q Trojanowski, Virginia M-Y Lee.   

Abstract

Although argyrophilic grain disease is characterized histopathologically by tau-positive lesions known as argyrophilic grains located predominantly in limbic brain regions in the absence of other diagnostic neuropathologies, the biochemical correlates of argyrophilic grains in gray and white matter have not been reported. Thus, we analyzed insoluble (pathological) tau proteins in five argyrophilic grain disease brains in comparison with those seen in Alzheimer's disease and Pick's disease. Analyses of separately dissected gray and white matter samples from various cortical regions revealed that pathological tau in argyrophilic grain disease was confined primarily to mediotemporal neocortical gray and adjacent white matter, and also to the allocortex, amygdala, and hippocampus. The amounts of sarcosyl-insoluble tau in all five cases were substantially lower than in Alzheimer's disease and Pick's disease, but the amounts of sarcosyl-insoluble tau in white matter were higher or comparable to that detected in gray matter from the same region, which distinguishes argyrophilic grain disease from Alzheimer's disease. The banding patterns of tau isoforms in argyrophilic grain disease varied: in three cases they were similar to Alzheimer's disease, but in two other cases, 4 microtubule binding repeat (4R) tau predominated, which distinguishes argyrophilic grain disease from classical Pick's disease. The differences between these three diseases were re-enforced by the predominance of straight tau filaments from argyrophilic grain disease brains. Thus, we conclude that argyrophilic grain disease is a distinct tauopathy characterized by prominent accumulation of argyrophilic grains in limbic brain regions in association with the characteristic tau biochemical and ultrastructural profile reported here.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368187      PMCID: PMC1867288          DOI: 10.1016/s0002-9440(10)64390-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.

Authors:  M E King; N Ghoshal; J S Wall; L I Binder; H Ksiezak-Reding
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Purification of paired helical filament tau and normal tau from human brain tissue.

Authors:  V M Lee; J Wang; J Q Trojanowski
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

3.  A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)

Authors:  M Yasuda; J Takamatsu; I D'Souza; R A Crowther; T Kawamata; M Hasegawa; H Hasegawa; M G Spillantini; S Tanimukai; P Poorkaj; L Varani; G Varani; T Iwatsubo; M Goedert; D G Schellenberg; C Tanaka
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

4.  Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation.

Authors:  C F Lippa; V Zhukareva; T Kawarai; K Uryu; M Shafiq; L E Nee; J Grafman; Y Liang; P H St George-Hyslop; J Q Trojanowski; V M Lee
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

5.  Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.

Authors:  V Zhukareva; V Vogelsberg-Ragaglia; V M Van Deerlin; J Bruce; T Shuck; M Grossman; C M Clark; S E Arnold; E Masliah; D Galasko; J Q Trojanowski; V M Lee
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

Review 6.  Argyrophilic grain disease. A frequent dementing disorder in aged patients.

Authors:  M Tolnay; A U Monsch; A Probst
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

7.  Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

Authors:  T Ishihara; M Hong; B Zhang; Y Nakagawa; M K Lee; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

Review 8.  Pathological changes in the parahippocampal region in select non-Alzheimer's dementias.

Authors:  H Braak; K Del Tredici; J Bohl; H Bratzke; E Braak
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 9.  Abnormal tau-containing filaments in neurodegenerative diseases.

Authors:  R A Crowther; M Goedert
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

10.  Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease.

Authors:  Takashi Togo; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2002-04-09       Impact factor: 17.088

View more
  20 in total

1.  A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease.

Authors:  Richard A Armstrong; Paul T Kotzbauer; Joel S Perlmutter; Meghan C Campbell; Kyle M Hurth; Robert E Schmidt; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2013-08-31       Impact factor: 3.575

Review 2.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

3.  Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.

Authors:  Gabor G Kovacs; Linda K Kwong; Murray Grossman; David J Irwin; Edward B Lee; John L Robinson; Eunran Suh; Vivianna M Van Deerlin; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-01-19       Impact factor: 6.508

4.  MRI signatures of the frontotemporal lobar degeneration continuum.

Authors:  Federica Agosta; Sebastiano Galantucci; Giuseppe Magnani; Alessandra Marcone; Daniele Martinelli; Maria Antonietta Volontè; Nilo Riva; Sandro Iannaccone; Pilar M Ferraro; Francesca Caso; Adriano Chiò; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-03-28       Impact factor: 5.038

5.  A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

Authors:  James Y Garbern; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee; Gerald Feldman; Joy W Norris; Michael J Friez; Charles E Schwartz; Roger Stevenson; Anders A F Sima
Journal:  Brain       Date:  2010-04-15       Impact factor: 13.501

6.  Acetylated tau neuropathology in sporadic and hereditary tauopathies.

Authors:  David J Irwin; Todd J Cohen; Murray Grossman; Steven E Arnold; Elisabeth McCarty-Wood; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2013-08       Impact factor: 4.307

7.  Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.

Authors:  Susana Boluda; Michiyo Iba; Bin Zhang; Kevin M Raible; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-12-24       Impact factor: 17.088

8.  EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease.

Authors:  Yancy Ferrer-Acosta; Eva N Rodríguez-Cruz; François Orange; Hector De Jesús-Cortés; Bismark Madera; Jaime Vaquer-Alicea; Juan Ballester; Maxime J-F Guinel; George S Bloom; Irving E Vega
Journal:  J Neurochem       Date:  2013-02-14       Impact factor: 5.372

9.  A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy.

Authors:  R A Armstrong; A C McKee; T D Stein; V E Alvarez; N J Cairns
Journal:  Neuropathol Appl Neurobiol       Date:  2016-04-15       Impact factor: 8.090

10.  A new subtype of frontotemporal lobar degeneration with FUS pathology.

Authors:  Manuela Neumann; Rosa Rademakers; Sigrun Roeber; Matt Baker; Hans A Kretzschmar; Ian R A Mackenzie
Journal:  Brain       Date:  2009-08-11       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.